Skip to main content

Table 1 Socio-demographic, anthropometric and obstetric characteristics of participants

From: Association of hyperlipidemia with breast cancer in Bangladeshi women

Variable

Categories

Control

Benign Breast Disease

Breast cancer

P-value

Age (years)

 

47.8 ± 10.0

49.6 ± 11.5

51.1 ± 9.8

0.282

≥ 45

33 (66)

39 (78)

39 (78)

0.287

18–45

17 (34.0)

11 (22.0)

11 (22.0)

 

Marital Status

Married

47 (94)

46 (92)

50 (100)

0.143

Single

3 (6)

4 (8)

0

 

Education

No education

9 (18)

8 (16)

10 (20)

0.995

Primary

14 (28)

16 (32)

14 (28)

 

SSC

8 (16)

9 (18)

7 (14)

 

HSC

7 (14)

6 (12)

5 (10)

 

Graduation and above

12 (24)

11 (22)

14 (28)

 

Occupation

Housewife

33 (66)

34 (68)

35 (70)

0.891

Service holder

8 (16)

8 (16)

9 (18)

 

Teacher

6 (12)

4 (8)

5 (10)

 

Others

3 (6)

4 (8)

1 (2)

 

Socio-economic status

Middle class

47 (94)

41 (82)

45 (90)

0.194

Lower class

3 (6)

9 (18)

5 (10)

 

Age menarche (years)

 

12.7 ± 1.0

12.6 ± 1.1

12.4 ± 0.9

0.412

< 12

6 (12)

8 (16)

8 (16)

0.808

≥ 12

44 (88)

42 (84)

42 (84)

 

Menopause

Yes

35 (70)

39 (78)

42 (84)

0.245

No

15 (30)

11 (22)

8 (16)

 

Age menopause (years)

 

46.0 ± 1.2

45.9 ± 1.1

46.4 ± 1.6

0.204

>  46

14 (40.0)

14 (35.9)

22 (52.4)

0.296

≤ 46

21 (60.0)

25 (64.1)

20 (47.6)

 

Age at first pregnancy (years)

 

18.40 ± 5.8

17.7 ± 6.3

19.6 ± 3.3

0.184

Number of pregnancies

 

2.8 ± 1.4

2.8 ± 1.4

3.1 ± 1.3

0.575

BMI (kg/m2)

 

22.5 ± 1.0

22.7 ± 1.1

25.1 ± 1.4*

< 0.001

Overweight (≥23)

15 (30)

21 (42)

49 (98)

< 0.001

Normal weight (18.5 to < 23)

35 (70)

29 (58)

1 (2)

 

Family history of breast cancer

Present

6 (12)

6 (12)

9 (18)

0.608

Absent

44 (88)

44 (88)

41 (82)

 
  1. Data expressed as n(%) and mean ± SD where appropriate; SSC Secondary School Certificate, HSC Higher Secondary Certificate, BMI Body Mass Index
  2. P-value was determined by Chi-square test and ANOVA with post-hoc analysis by Bonferroni adjustments where appropriate
  3. *P-value significant at < 0.05 level in comparison to control and benign breast disease